{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:06:40Z","timestamp":1773274000060,"version":"3.50.1"},"reference-count":88,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["PTDC\/SAU-TOX\/121887\/2010"],"award-info":[{"award-number":["PTDC\/SAU-TOX\/121887\/2010"]}]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["SFRH\/BD\/71042\/2010"],"award-info":[{"award-number":["SFRH\/BD\/71042\/2010"]}]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["SFRH\/BD\/51678\/2011"],"award-info":[{"award-number":["SFRH\/BD\/51678\/2011"]}]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["SFRH\/BPD\/79323\/2011"],"award-info":[{"award-number":["SFRH\/BPD\/79323\/2011"]}]},{"DOI":"10.13039\/501100011929","name":"COMPETE","doi-asserted-by":"crossref","award":["Centro-07-ST24-FEDER-002008"],"award-info":[{"award-number":["Centro-07-ST24-FEDER-002008"]}],"id":[{"id":"10.13039\/501100011929","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.bbrc.2015.10.014","type":"journal-article","created":{"date-parts":[[2015,10,24]],"date-time":"2015-10-24T00:12:38Z","timestamp":1445645558000},"page":"710-718","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Vascular disease modeling using induced pluripotent stem cells: Focus in Hutchinson-Gilford Progeria Syndrome"],"prefix":"10.1016","volume":"473","author":[{"given":"P.R.","family":"Pitrez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.C.","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Pra\u00e7a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2015.10.014_bib1","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1126\/science.1158799","article-title":"Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons","volume":"321","author":"Dimos","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2015.10.014_bib2","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.cell.2008.07.041","article-title":"Disease-specific induced pluripotent stem cells","volume":"134","author":"Park","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2015.10.014_bib3","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nbt.2710","article-title":"What is the point of large-scale collections of human induced pluripotent stem cells?","volume":"31","author":"McKernan","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbrc.2015.10.014_bib4","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrd3577","article-title":"Induced pluripotent stem cells\u2013opportunities for disease modelling and drug discovery","volume":"10","author":"Grskovic","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2015.10.014_bib5","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nrg3764","article-title":"Investigating human disease using stem cell models","volume":"15","author":"Sterneckert","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbrc.2015.10.014_bib6","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a014027","article-title":"Pluripotent stem cell models of human heart disease","volume":"3","author":"Moretti","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.bbrc.2015.10.014_bib7","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jacc.2014.05.038","article-title":"Induced pluripotent stem cells for the study of cardiovascular disease","volume":"64","author":"Savla","year":"2014","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.bbrc.2015.10.014_bib8","doi-asserted-by":"crossref","first-page":"18894","DOI":"10.3390\/ijms160818894","article-title":"Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells","volume":"16","author":"Tanaka","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2015.10.014_bib9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nbt.2107","article-title":"Generation of human vascular smooth muscle subtypes provides insight into embryological origin-dependent disease susceptibility","volume":"30","author":"Cheung","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbrc.2015.10.014_bib10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1161\/ATVBAHA.113.302598","article-title":"Functionality of endothelial cells and pericytes from human pluripotent stem cells demonstrated in cultured vascular plexus and zebrafish xenografts","volume":"34","author":"Orlova","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2015.10.014_bib11","first-page":"21","article-title":"Human induced pluripotent stem cell-derived endothelial cells exhibit functional heterogeneity","volume":"5","author":"Rufaihah","year":"2013","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.bbrc.2015.10.014_bib12","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ncb3161","article-title":"Human definitive haemogenic endothelium and arterial vascular endothelium represent distinct lineages","volume":"17","author":"Ditadi","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbrc.2015.10.014_bib13","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/ncb3205","article-title":"Generation of vascular endothelial and smooth muscle cells from human pluripotent stem cells","volume":"17","author":"Patsch","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbrc.2015.10.014_bib14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pharmthera.2010.10.004","article-title":"Pluripotent stem cell differentiation into vascular cells: a novel technology with promises for vascular re(generation)","volume":"129","author":"Kane","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2015.10.014_bib15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nbt.1605","article-title":"Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGFbeta inhibition is Id1 dependent","volume":"28","author":"James","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbrc.2015.10.014_bib16","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/bit.21809","article-title":"The response of human embryonic stem cell-derived endothelial cells to shear stress","volume":"100","author":"Metallo","year":"2008","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.bbrc.2015.10.014_bib17","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1161\/ATVBAHA.109.193185","article-title":"Shear stress increases expression of the arterial endothelial marker EphrinB2 in Murine ES cells via the VEGF-notch signaling pathways","volume":"29","author":"Masumura","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2015.10.014_bib18","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.biomaterials.2015.02.121","article-title":"Arterial specification of endothelial cells derived from human induced pluripotent stem cells in a biomimetic flow bioreactor","volume":"53","author":"Sivarapatna","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbrc.2015.10.014_bib19","doi-asserted-by":"crossref","first-page":"8960","DOI":"10.1016\/j.biomaterials.2014.07.011","article-title":"Engineering vascular tissue with functional smooth muscle cells derived from human iPS cells and nanofibrous scaffolds","volume":"35","author":"Wang","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbrc.2015.10.014_bib20","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1016\/j.biomaterials.2011.02.049","article-title":"Three-dimensional growth of iPS cell-derived smooth muscle cells on nanofibrous scaffolds","volume":"32","author":"Xie","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbrc.2015.10.014_bib21","doi-asserted-by":"crossref","first-page":"E2261","DOI":"10.1073\/pnas.1320843111","article-title":"Mechanisms controlling the smooth muscle cell death in progeria via down-regulation of poly(ADP-ribose) polymerase 1","volume":"111","author":"Zhang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2015.10.014_bib22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.stem.2010.12.002","article-title":"A\u00a0human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects","volume":"8","author":"Zhang","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbrc.2015.10.014_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.celrep.2012.05.015","article-title":"Unique preservation of neural cells in Hutchinson- Gilford progeria syndrome is due to the expression of the neural-specific miR-9 microRNA","volume":"2","author":"Nissan","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbrc.2015.10.014_bib24","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature06894","article-title":"Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population","volume":"453","author":"Yang","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2015.10.014_bib25","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/CIRCRESAHA.107.150201","article-title":"Vascular progenitor cells isolated from human embryonic stem cells give rise to endothelial and smooth muscle\u00e2\u20ac\u201clike cells and form vascular networks in\u00a0vivo","volume":"101","author":"Ferreira","year":"2007","journal-title":"Circulation Res."},{"key":"10.1016\/j.bbrc.2015.10.014_bib26","doi-asserted-by":"crossref","first-page":"e17771","DOI":"10.1371\/journal.pone.0017771","article-title":"Towards the Maturation and Characterization of Smooth Muscle Cells Derived from Human Embryonic Stem Cells","volume":"6","author":"Vaz\u00e3o","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2015.10.014_bib27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.scr.2012.10.003","article-title":"Derivation of endothelial cells from human embryonic stem cells in fully defined medium enables identification of lysophosphatidic acid and platelet activating factor as regulators of eNOS localization","volume":"10","author":"Costa","year":"2013","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.bbrc.2015.10.014_bib28","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1182\/blood-2007-02-074120","article-title":"Short-term BMP-4 treatment initiates mesoderm induction in human embryonic stem cells","volume":"111","author":"Zhang","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2015.10.014_bib29","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1002\/stem.100","article-title":"A\u00a0Boost of BMP4 Accelerates the Commitment of Human Embryonic Stem Cells to the Endothelial Lineage","volume":"27","author":"Goldman","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.bbrc.2015.10.014_bib30","doi-asserted-by":"crossref","first-page":"10623","DOI":"10.1073\/pnas.1434429100","article-title":"Endothelial cell diversity revealed by global expression profiling","volume":"100","author":"Chi","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbrc.2015.10.014_bib31","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1161\/CIRCRESAHA.113.300506","article-title":"Regulation of endothelial cell differentiation and specification","volume":"112","author":"Marcelo","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2015.10.014_bib32","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1242\/dev.00929","article-title":"Flow regulates arterial-venous differentiation in the chick embryo yolk sac","volume":"131","author":"le Noble","year":"2004","journal-title":"Development"},{"key":"10.1016\/j.bbrc.2015.10.014_bib33","first-page":"21","article-title":"Human induced pluripotent stem cell-derived endothelial cells exhibit functional heterogeneity","volume":"5","author":"Rufaihah","year":"2013","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.bbrc.2015.10.014_bib34","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1161\/01.RES.0000255690.03436.ae","article-title":"Phenotypic Heterogeneity of the Endothelium: II. Representative Vascular Beds","volume":"100","author":"Aird","year":"2007","journal-title":"Circulation Res."},{"key":"10.1016\/j.bbrc.2015.10.014_bib35","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/bit.21809","article-title":"The response of human embryonic stem cell-derived endothelial cells to shear stress","volume":"100","author":"Metallo","year":"2008","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.bbrc.2015.10.014_bib36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.stemcr.2013.06.007","article-title":"Functional vascular endothelium derived from human induced pluripotent stem cells","volume":"1","author":"Adams","year":"2013","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.bbrc.2015.10.014_bib37","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.gim.0000218152.87434.f3","article-title":"Pompe disease diagnosis and management guideline","volume":"8","author":"A.W.G.o.M.o.P. Disease","year":"2006","journal-title":"Genet. Med."},{"key":"10.1016\/j.bbrc.2015.10.014_bib38","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/mus.10381","article-title":"Morphological changes in muscle tissue of patients with infantile Pompe's disease receiving enzyme replacement therapy","volume":"27","author":"Winkel","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.bbrc.2015.10.014_bib39","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1212\/01.WNL.0000149528.95362.20","article-title":"Mutations in the acid alpha-glucosidase gene (M. Pompe) in a patient with an unusual phenotype","volume":"64","author":"Anneser","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.bbrc.2015.10.014_bib40","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1093\/hmg\/ddr424","article-title":"Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification","volume":"20","author":"Huang","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2015.10.014_bib41","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ymgme.2014.02.012","article-title":"The generation of induced pluripotent stem cells (iPSCs) from patients with infantile and late-onset types of Pompe disease and the effects of treatment with acid-alpha-glucosidase in Pompe's iPSCs","volume":"112","author":"Higuchi","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbrc.2015.10.014_bib42","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1161\/CIRCULATIONAHA.112.116996","article-title":"Modeling supravalvular aortic stenosis syndrome with human induced pluripotent stem cells","volume":"126","author":"Ge","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2015.10.014_bib43","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/30522","article-title":"Elastin is an essential determinant of arterial morphogenesis","volume":"393","author":"Li","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2015.10.014_bib44","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5966\/sctm.2012-0054","article-title":"Modeling and rescue of the vascular phenotype of Williams-Beuren syndrome in patient induced pluripotent stem cells","volume":"2","author":"Kinnear","year":"2013","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.bbrc.2015.10.014_bib45","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1177\/095952878606900127","article-title":"Congenital absence of hair and mammary glands with atrophic condition of the skin and its appendages, in a boy whose mother had been almost wholly bald from Alopecia areata from the age of six","volume":"69","author":"Hutchinson","year":"1886","journal-title":"Med. Chir. Trans."},{"key":"10.1016\/j.bbrc.2015.10.014_bib46","article-title":"On a condition of mixed premature and immature development","volume":"80","author":"Gilford","year":"1897","journal-title":"Med. Chir. Trans."},{"key":"10.1016\/j.bbrc.2015.10.014_bib47","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1042\/BST20110659","article-title":"In\u00a0vitro pathological modelling using patient-specific induced pluripotent stem cells: the case of progeria","volume":"39","author":"Nissan","year":"2011","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbrc.2015.10.014_bib48","first-page":"65","article-title":"Hutchinson-Gilford Progeria Syndrome","author":"Baek","year":"2013","journal-title":"Genet. Disord."},{"key":"10.1016\/j.bbrc.2015.10.014_bib49","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1002\/ajmg.a.31346","article-title":"Hutchinson-Gilford progeria syndrome: review of the phenotype","volume":"140","author":"Hennekam","year":"2006","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bbrc.2015.10.014_bib50","series-title":"PRF by the Numbers","author":"Gordon","year":"2015"},{"key":"10.1016\/j.bbrc.2015.10.014_bib51","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1161\/ATVBAHA.110.209460","article-title":"Cardiovascular pathology in Hutchinson-Gilford progeria: correlation with the vascular pathology of aging","volume":"30","author":"Olive","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2015.10.014_bib52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1161\/CIRCRESAHA.107.153692","article-title":"Mechanisms of cardiovascular disease in accelerated aging syndromes","volume":"101","author":"Capell","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2015.10.014_bib53","doi-asserted-by":"crossref","first-page":"26","DOI":"10.18632\/aging.100717","article-title":"Signaling pathway activation drift during aging: Hutchinson-Gilford Progeria Syndrome fibroblasts are comparable to normal middle-age and old-age cells","volume":"7","author":"Aliper","year":"2015","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bbrc.2015.10.014_bib54","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.2741\/226","article-title":"Hutchinson-Gilford progeria syndrome, cardiovascular disease and oxidative stress","volume":"3","author":"Trigueros-Motos","year":"2011","journal-title":"Front. Biosci. Sch. Ed."},{"key":"10.1016\/j.bbrc.2015.10.014_bib55","series-title":"Geriatric Medicine and Gerontology","first-page":"66","article-title":"The premature aging syndrome Hutchinson-Gilford Progeria Syndrome: insights into normal aging","author":"Gordon","year":"2010"},{"key":"10.1016\/j.bbrc.2015.10.014_bib56","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.mad.2008.04.003","article-title":"HGPS and related premature aging disorders: from genomic identification to the first therapeutic approaches","volume":"129","author":"Pereira","year":"2008","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.bbrc.2015.10.014_bib57","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1126\/science.1127168","article-title":"Lamin A-dependent nuclear defects in human aging","volume":"312","author":"Scaffidi","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2015.10.014_bib58","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1399-0004.2004.00315.x","article-title":"Hutchinson-Gilford progeria syndrome","volume":"66","author":"Pollex","year":"2004","journal-title":"Clin. Genet."},{"key":"10.1016\/j.bbrc.2015.10.014_bib59","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.semcdb.2014.03.021","article-title":"Nuclear matrix, nuclear envelope and premature aging syndromes in a translational research perspective","volume":"29","author":"Cau","year":"2014","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.bbrc.2015.10.014_bib60","series-title":"Neurodegenerative Diseases","first-page":"317","article-title":"Premature aging syndrome","author":"Copped\u00e8","year":"2012"},{"key":"10.1016\/j.bbrc.2015.10.014_bib61","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1161\/HYPERTENSIONAHA.111.180919","article-title":"Mechanisms of premature vascular aging in children with Hutchinson-Gilford progeria syndrome","volume":"59","author":"Gerhard-Herman","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.bbrc.2015.10.014_bib62","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1054-8807(01)00069-2","article-title":"Smooth muscle cell depletion and collagen types in progeric arteries","volume":"10","author":"Stehbens","year":"2001","journal-title":"Cardiovasc Pathol."},{"key":"10.1016\/j.bbrc.2015.10.014_bib63","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/nrg1906","article-title":"Human laminopathies: nuclei gone genetically awry","volume":"7","author":"Capell","year":"2006","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbrc.2015.10.014_bib64","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrm1550","article-title":"The nuclear lamina comes of age","volume":"6","author":"Gruenbaum","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2015.10.014_bib65","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1126\/science.1084125","article-title":"Lamin a truncation in Hutchinson-Gilford progeria","volume":"300","author":"De Sandre-Giovannoli","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2015.10.014_bib66","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nature01629","article-title":"Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome","volume":"423","author":"Eriksson","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2015.10.014_bib67","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/jmg.2004.019323","article-title":"Lamin A expression levels are unperturbed at the normal and mutant alleles but display partial splice site selection in Hutchinson-Gilford progeria syndrome","volume":"41","author":"Reddel","year":"2004","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.bbrc.2015.10.014_bib68","series-title":"Hutchinson-Gilford Progeria Syndrome","author":"Gordon LB","year":"2003"},{"key":"10.1016\/j.bbrc.2015.10.014_bib69","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1056\/NEJMra0907180","article-title":"New therapeutic approaches to mendelian disorders","volume":"363","author":"Dietz","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2015.10.014_bib70","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/1753425914548491","article-title":"Sustained expression of lipocalin-2 during polymicrobial sepsis","volume":"21","author":"Vazquez","year":"2014","journal-title":"Innate Immun."},{"key":"10.1016\/j.bbrc.2015.10.014_bib71","doi-asserted-by":"crossref","first-page":"8963","DOI":"10.1073\/pnas.0402943101","article-title":"Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome","volume":"101","author":"Goldman","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2015.10.014_bib72","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cell.2013.12.028","article-title":"Progeria: a paradigm for translational medicine","volume":"156","author":"Gordon","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2015.10.014_bib73","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09879","article-title":"Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome","volume":"472","author":"Liu","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2015.10.014_bib74","doi-asserted-by":"crossref","first-page":"380","DOI":"10.18632\/aging.100277","article-title":"Generation of induced pluripotent stem cell lines from 3 distinct laminopathies bearing heterogeneous mutations in lamin A\/C","volume":"3","author":"Ho","year":"2011","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bbrc.2015.10.014_bib75","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/scrt69","article-title":"Dedifferentiation rescues senescence of progeria cells but only while pluripotent","volume":"2","author":"Niedernhofer","year":"2011","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.bbrc.2015.10.014_bib76","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ceb.2012.08.009","article-title":"Reprogramming aging and progeria","volume":"24","author":"Freije","year":"2012","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bbrc.2015.10.014_bib77","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1634\/stemcells.2004-0159","article-title":"Lamin A\/C expression is a marker of mouse and human embryonic stem cell differentiation","volume":"24","author":"Constantinescu","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.bbrc.2015.10.014_bib78","doi-asserted-by":"crossref","first-page":"288","DOI":"10.18632\/aging.100550","article-title":"An inhibitory role of progerin in the gene induction network of adipocyte differentiation from iPS cells","volume":"5","author":"Xiong","year":"2013","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bbrc.2015.10.014_bib79","doi-asserted-by":"crossref","first-page":"e87273","DOI":"10.1371\/journal.pone.0087273","article-title":"An upregulation in the expression of vanilloid transient potential channels 2 enhances hypotonicity-induced cytosolic Ca(2)(+) rise in human induced pluripotent stem cell model of Hutchinson-Gillford Progeria","volume":"9","author":"Lo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2015.10.014_bib80","doi-asserted-by":"crossref","first-page":"E423","DOI":"10.1073\/pnas.1111780109","article-title":"Regulation of prelamin A but not lamin C by miR-9, a brain-specific microRNA","volume":"109","author":"Jung","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2015.10.014_bib81","doi-asserted-by":"crossref","first-page":"12879","DOI":"10.1073\/pnas.0506001102","article-title":"Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome","volume":"102","author":"Capell","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2015.10.014_bib82","doi-asserted-by":"crossref","first-page":"510","DOI":"10.5966\/sctm.2013-0168","article-title":"Induced pluripotent stem cells reveal functional differences between drugs currently investigated in patients with hutchinson-gilford progeria syndrome","volume":"3","author":"Blondel","year":"2014","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.bbrc.2015.10.014_bib83","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.stem.2011.04.019","article-title":"Targeted Gene Correction of laminopathy-associated LMNA mutations in patient-specific iPSCs","volume":"8","author":"Liu","year":"2011","journal-title":"Cell Stem cell"},{"key":"10.1016\/j.bbrc.2015.10.014_bib84","doi-asserted-by":"crossref","first-page":"16666","DOI":"10.1073\/pnas.1202529109","article-title":"Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome","volume":"109","author":"Gordon","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2015.10.014_bib85","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1126\/science.337.6102.1594","article-title":"Medicine. Drug trial offers uncertain start in race to save children with progeria","volume":"337","author":"Couzin-Frankel","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2015.10.014_bib86","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ceb.2012.08.014","article-title":"iPSC technology to study human aging and aging-related disorders","volume":"24","author":"Liu","year":"2012","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bbrc.2015.10.014_bib87","doi-asserted-by":"crossref","first-page":"889","DOI":"10.18632\/aging.100383","article-title":"Accelerated aging syndromes, are they relevant to normal human aging?","volume":"3","author":"Dreesen","year":"2011","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bbrc.2015.10.014_bib88","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1161\/01.ATV.0000136392.59656.8b","article-title":"Laminopathies and atherosclerosis","volume":"24","author":"Al-Shali","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X15307154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X15307154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T00:58:39Z","timestamp":1589590719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X15307154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":88,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0006291X15307154"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2015.10.014","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vascular disease modeling using induced pluripotent stem cells: Focus in Hutchinson-Gilford Progeria Syndrome","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2015.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}